Inventor · disambiguated record
Katherine Donovan
Also filed as: DONOVAN KATHERINE · DONOVAN KATHERINE A
10 granted patents·12 pending applications·7 citations·filing 2018–2023
79Inventor score
Files withDANA FARBER CANCER INST INC22
Top patents by PatentIndex Score
22 records- 0187US11530219B2Ligands to cereblon (CRBN)DANA FARBER CANCER INST INC·Filed 2019·Granted Dec 20, 2022·3 cites·15 claims
- 0284US11807606B2Sulfonamide derivatives for protein degradationDANA FARBER CANCER INST INC·Filed 2019·Granted Nov 7, 2023·4 cites·24 claims
- 0376US2024142437A1Methods to prevent teratogenicity of imid like molecules and imid based degraders/protacsDANA FARBER CANCER INST INC·Filed 2023·Application pending·0 cites
- 0474US12110292B2Ligands to cereblon (CRBN)DANA FARBER CANCER INST INC·Filed 2022·Granted Oct 8, 2024·0 cites·16 claims
- 0563US2025387491A1Selective histone deacetylase 8 (hdac8) degraders and methods of use thereofDANA FARBER CANCER INST INC·Filed 2023·Application pending·0 cites
- 0658US2024246956A1Class iia histone deacetylase (hdac) degrader ligands and methods of use thereofDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 0756US2024277852A1Inhibitors and degraders of pip4k proteinDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 0855US11771697B2Small molecule degraders of polybromo-1 (PBRM1)DANA FARBER CANCER INST INC·Filed 2019·Granted Oct 3, 2023·0 cites·8 claims
- 0955US2024245786A1Small molecule degraders of phosphatidylinositol-5-phosphate 4-kinase type 2 and uses thereofDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 1054US2024269139A1Compounds for targeted protein degradation of kinasesDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 1154US2020348285A1Methods to prevent teratogenicity of imid like molecules and imid based degraders/protacsDANA FARBER CANCER INST INC·Filed 2018·Application pending·0 cites
- 1251US12030892B2CRBN modulatorsDANA FARBER CANCER INST INC·Filed 2019·Granted Jul 9, 2024·0 cites·19 claims
- 1349US12466809B2CDK2/5 degraders and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Granted Nov 11, 2025·0 cites·27 claims
- 1449US12318452B2Degraders of WEE1 kinaseDANA FARBER CANCER INST INC·Filed 2019·Granted Jun 3, 2025·0 cites·19 claims
- 1547US2022387604A1Selective dual histone deacetylase 6/8 (hdac6/8) degraders and methods of use thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 1647US2022177466A1Degraders of kelch-like ech-associated protein 1 (keap1)DANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 1746US2022226481A1Degradation of akt by conjugation of atp-competitive akt inhibitor gdc-0068 with e3 ligase ligands and methods of useDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 1845US2022401564A1Selective histone deacetylase (hdac) degraders and methods of use thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 1944US12365677B2Degraders that target proteins via KEAP1DANA FARBER CANCER INST INC·Filed 2019·Granted Jul 22, 2025·0 cites·11 claims
- 2044US12234220B2Immunomodulatory compoundsDANA FARBER CANCER INST INC·Filed 2019·Granted Feb 25, 2025·0 cites·42 claims
- 2144US12060366B2Bispecific degradersDANA FARBER CANCER INST INC·Filed 2019·Granted Aug 13, 2024·0 cites·20 claims
- 2240US2021002295A1Small molecule degraders that recruit dcaf15DANA FARBER CANCER INST INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Katherine Donovan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →